Schlecht S
Zentralbl Bakteriol A. 1981 Aug;249(3):362-72.
Mice (NMRI) were immunized twice with acetone-killed bacteria from 13 different Salmonella R-mutant and 6 Salmonella S form strains. Of the R mutants one strain was a semirough mutant, 9 strains belonged to the chemotype Ra, one to chemotype Rb2 and 2 to chemotype Re. Of the S forms 2 strains derived from serological group B, 2 from group D1 and one strain from each of group C1 and C2. Ten days after immunization the animals were challenged with increasing numbers of S-form bacteria (the same S strains as those used for immunization) administered intraperitoneally. The virulence (LD50) of the strains used was between 6 x 10(2) and 3 x 10(5) cells. The results show that every mutant was capable of affording protection to the S-form bacteria used, i.e. the protection was not confined to the species used for immunization; nevertheless differences in the degree of protection were present. These differences were found both in the ability of the different mutants to protect towards the same infecting microorganism and in the protection obtained by individual mutants towards infection with the different S-forms. With certain strains a relatively high degree of protection was obtained, with others the protection was low compared to that seen with homologous S form vaccines. In infection with s. typhimurium, unlike infection with other S-forms, the homologous R mutants were superior to the other mutants in their immunizing properties. Immunization with heterologous S-forms yielded similar results as those obtained with R mutants. S-forms with identical O-antigens were not necessarily comparable in their protective properties. Although the protective effect of R mutants was generally lower than that produced by homologous S-form vaccines, the present results show that in a few cases an equally high protection may also be obtained by R mutants. The present results lead to the conclusion that the cell-surface of Salmonella contains, in addition to the known antigens, other components playing an important role in inducing immunity to infection. A partial divergence in the pattern of such components among the different vaccines, would explain the extension of immunity obtained by the heterologous species also.
用来自13种不同沙门氏菌R突变株和6种沙门氏菌S型菌株的丙酮灭活细菌对NMRI小鼠进行两次免疫。在R突变株中,一株是半粗糙突变株,9株属于化学型Ra,一株属于化学型Rb2,2株属于化学型Re。在S型菌株中,2株来自血清群B,2株来自群D1,群C1和C2各有1株。免疫10天后,给动物腹腔注射数量不断增加的S型细菌(与用于免疫的S菌株相同)。所用菌株的毒力(LD50)在6×10²至3×10⁵个细胞之间。结果表明,每个突变株都能够为所用的S型细菌提供保护,即这种保护并不局限于用于免疫的菌株;然而,保护程度存在差异。这些差异既体现在不同突变株对同一感染微生物的保护能力上,也体现在单个突变株对不同S型菌株感染的保护效果上。某些菌株能获得较高程度的保护,而其他菌株与同源S型疫苗相比保护作用较低。在鼠伤寒沙门氏菌感染中,与其他S型菌株感染不同,同源R突变株在免疫特性上优于其他突变株。用异源S型菌株免疫产生的结果与用R突变株获得的结果相似。具有相同O抗原的S型菌株在保护特性上不一定具有可比性。虽然R突变株的保护作用通常低于同源S型疫苗产生的保护作用,但目前的结果表明,在少数情况下,R突变株也可能获得同样高的保护。目前的结果得出结论,沙门氏菌的细胞表面除了已知抗原外,还含有其他在诱导感染免疫中起重要作用的成分。不同疫苗中这些成分模式的部分差异,也可以解释异源菌株获得的免疫范围。